TerrAscend (TSNDF) Dividends Paid - Common (2022 - 2023)
TerrAscend's (TSNDF) quarterly Dividends Paid - Common came in at -$7.0 million in Q4 2023, down 6863.11% year-on-year from $103000.0 in Q4 2022, and down 296.17% on a QoQ basis from $3.6 million in Q3 2023.
TerrAscend (TSNDF) Dividends Paid - Common (2022 - 2023) Analysis & Trends
TerrAscend (TSNDF) has 2 years of Dividends Paid - Common data on file, last reported at -$7.0 million in Q4 2023.
- On a quarterly basis, Dividends Paid - Common fell 6863.11% year-over-year to -$7.0 million in Q4 2023; TTM through Dec 2023 was -$3.3 million, a N/A change from a year earlier, with the FY2022 full-year figure at $1.5 million, changed N/A from the prior year.
- Dividends Paid - Common for Q4 2023 stood at -$7.0 million, down from $3.6 million in the prior quarter.
- Over the last five years, Dividends Paid - Common for TSNDF reached as high as $3.6 million in Q3 2023 and fell as low as -$7.0 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 224.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.92 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 139.60 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -6.97 Mn |
| Dec 31, 2023 | -6.97 Mn |
| Sep 30, 2023 | 3.55 Mn |
| Sep 30, 2023 | 3.55 Mn |
| Dec 31, 2022 | 103,000.00 |
| Dec 31, 2022 | 103,000.00 |